Browsing Modes for Business Users

CD45 antibody | F10-89-4

Mouse anti Human CD45:StarBright Yellow 665

Product Type
Monoclonal Antibody
Clone
F10-89-4
Isotype
IgG2a
Specificity
CD45

Product Code Applications Pack Size List Price Your Price Qty
MCA87SBY665
Datasheet Datasheet Datasheet
SDS Safety Datasheet SDS
F 100 Tests/0.5ml loader
List Price Your Price
loader

Mouse anti Human CD45 antibody, clone F10-89-4 recognizes the human CD45 cell surface antigen, also known as leucocyte common antigen (LCA). CD45 is a complex molecule existing in a number of isoforms.

Antibodies recognizing a common epitope on all of these isoforms are termed CD45 whilst those recognizing only individual isoforms are termed CD45RA or CD45RO etc.

Mouse anti Human CD45 antibody, clone F10-89-4 reacts with all forms of CD45 expressed by all haematopoietic cells, except erythrocytes, having a higher level of expression on lymphocytes than on granulocytes. It is routinely tested in flow cytometry on human peripheral blood leucocytes.

Mouse anti Human CD45 antibody, clone F10-89-4, has been validated for use on the Genesis Cell Isolation System with the CelSelect SlideTM technology.
Rare Cell/CTC Enumeration

Target Species
Human
Product Form
Purified IgG conjugated to StarBright Yellow 665 - liquid
Preparation
Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant
Buffer Solution
Phosphate buffered saline
Preservative Stabilisers
0.09% Sodium Azide (NaN3)
1% Bovine Serum Albumin
0.1% Pluronic F68
0.1% PEG 3350
0.05% Tween 20
Immunogen
Human T lymphocytes.
Fusion Partners
Spleen cells from immunized BALB/c mice were fused with cells of the mouse NS-1 myeloma cell line.
Max Ex/Em
Fluorophore Excitation Max (nm) Emission Max (nm)
StarBright Yellow 665 554 670
Regulatory
For research purposes only
Guarantee
12 months from date of despatch
Acknowledgements
This product is covered by U.S. Patent No. 10,150,841 and related U.S. and foreign counterparts

Store at +4°C. DO NOT FREEZE.
This product should be stored undiluted.

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.
Application Name Verified Min Dilution Max Dilution
Flow Cytometry Neat
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Flow Cytometry
Use 5μl of the suggested working dilution to label 106 cells in 100μl. Best practices suggest a 5 minutes centrifugation at 6,000g prior to sample application.

How to Use the Spectraviewer

Watch the Tool Tutorial Video ▸
  • Start by selecting the application you are interested in, with the option to select an instrument from the drop down menu or create a customized instrument
  • Select the fluorophores or fluorescent proteins you want to include in your panel to check compatibility
  • Select the lasers and filters you wish to include
  • Select combined or multi-laser view to visualize the spectra

Description Product Code Applications Pack Size List Price Your Price Quantity
Human Seroblock BUF070A F 50 Test
List Price Your Price
Description Human Seroblock
Human Seroblock BUF070B F 200 Test
List Price Your Price
Description Human Seroblock

Source Reference

  1. Dalchau, R. et al. (1980) Monoclonal antibody to a human leukocyte-specific membrane glycoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat.
    Eur J Immunol. 10 (10): 737-44.

References for CD45 antibody

  1. Quenby, S et al. (1999) Pre-implantation endometrial leukocytes in women with recurrent miscarriage.
    Human Reprod. 14(9):2386-2391.
  2. Hauser, P.V. et al. (2010) Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery.
    Am J Pathol. 177: 2011-21.
  3. Mallam, E. et al. (2010) Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.
    Mult Scler. 16: 909-18.
  4. Marrinucci, D. et al. (2010) Cytomorphology of circulating colorectal tumor cells:a small case series.
    J Oncol. 2010: 861341.
  5. Paul, G. et al. (2012) The adult human brain harbors multipotent perivascular mesenchymal stem cells.
    PLoS One. 7: e35577.
  6. De Schauwer, C. et al. (2012) In search for cross-reactivity to immunophenotype equine mesenchymal stromal cells by multicolor flow cytometry.
    Cytometry A. 81 (4): 312-23.
  7. Kazane, S.A. et al. (2012) Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR.
    Proc Natl Acad Sci U S A. 109: 3731-6.
  8. Spaas, J.H. et al. (2013) Culture and characterisation of equine peripheral blood mesenchymal stromal cells.
    Vet J. 195 (1): 107-13.
  9. View The Latest Product References
  10. Sadarangani, A. et al. (2015) GLI2 inhibition abrogates human leukemia stem cell dormancy.
    J Transl Med. 13: 98.
  11. Gunawardene, P. et al. (2015) Association Between Circulating Osteogenic Progenitor Cells and Disability and Frailty in Older Persons: The Nepean Osteoporosis and Frailty Study.
    J Gerontol A Biol Sci Med Sci. pii: glv190.
  12. Mohamed Suhaimi, N.A. et al. (2015) Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients.
    Mol Oncol. 9 (4): 850-60.
  13. Ruiz, C. et al. (2015) Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
    Phys Biol. 12 (1): 016008.
  14. Gogoi P et al. (2016) Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.
    PLoS One. 11 (1): e0147400.
  15. Gomiero, C. et al. (2016) Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology.
    Vet Res Commun. 40 (1): 39-48.
  16. Bianchessi, M. et al. (2016) Effect of Fibroblast Growth Factor 2 on Equine Synovial Fluid Chondroprogenitor Expansion and Chondrogenesis.
    Stem Cells Int. 2016: 9364974.
  17. Branly, T. et al. (2017) Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-β1.
    Stem Cell Rev Rep. 13 (5): 611-30.
  18. GarikipatiV, N.S. et al. (2018) Isolation and characterization of mesenchymal stem cells from human fetus heart.
    PLoS One. 13 (2): e0192244.
  19. Shishido, S.N. et al. (2019) Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.
    J Transl Med. 17 (1): 294.
  20. Welter, L. et al. (2020) Treatment response and tumor evolution: lessons from an extended series of multianalyte liquid biopsies in a metastatic breast cancer patient.
    Cold Spring Harb Mol Case Stud. 6 (6): a005819.
  21. Ndacayisaba, L.J. et al. (2022) Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones
    Curr Oncol. 29 (5): 2954-72.
  22. Shishido, S.N. et al. (2022) Liquid Biopsy Landscape in Patients with Primary Upper Tract Urothelial Carcinoma.
    Cancers (Basel). 14 (12): 3007.
  23. Chai, S. et al. (2022) Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case.
    NPJ Precis Oncol. 6 (1): 41.
  24. Zhu, J. et al. (2022) Sequential Method for Analysis of CTCs and Exosomes from the Same Sample of Patient Blood.
    ACS Omega. 7 (42): 37581-88.
  25. Setayesh, S.M. et al. (2022) Multianalyte liquid biopsy to aid the diagnostic workup of breast cancer.
    NPJ Breast Cancer. 8 (1): 112.
  26. Ndacayisaba, L.J. et al. (2022) Characterization of BCMA Expression in Circulating Rare Single Cells of Patients with Plasma Cell Neoplasms.
    Int J Mol Sci. 23 (21): 13427.
  27. Qi, E. et al. (2023) Investigation of liquid biopsy analytes in peripheral blood of individuals after SARS-CoV-2 infection.
    EBioMedicine. 90: 104519.
  28. Seo, J. et al. (2023) Plasticity of circulating tumor cells in small cell lung cancer.
    Sci Rep. 13 (1): 11775.
  29. Setayesh, S.M. et al. (2023) Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma.
    NPJ Precis Oncol. 7 (1): 95.
  30. Welter, L. et al. (2023) Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics.
    Cancers (Basel). 15 (15): 3949.
  31. Shishido, S.N. et al. (2024) Cancer-related cells and oncosomes in the liquid biopsy of pancreatic cancer patients undergoing surgery.
    NPJ Precis Oncol. 8 (1): 36.
  32. Bai, L. et al. (2024) Longitudinal tracking of circulating rare events in the liquid biopsy of stage III-IV non-small cell lung cancer patients.
    Discov Oncol. 15 (1): 142.
  33. Shishido, S.N. et al. (2024) Determining the efficacy of ExThera Seraph100 blood filtration in patients diagnosed with pancreatic cancer through the liquid biopsy
    BJC Reports. 2: 47.
  34. Moellerberndt, J. et al. (2024) Impact of platelet lysate on immunoregulatory characteristics of equine mesenchymal stromal cells.
    Front Vet Sci. 11: 1385395.
  35. Schmidt, M.J. et al. (2024) Polyploid cancer cells reveal signatures of chemotherapy resistance.
    bioRχiv. Aug 23 [Preprint].

Flow Cytometry

Immunofluorescence

Synonyms
LCA
UniProt
P08575
Entrez Gene
PTPRC
GO Terms
GO:0001915 negative regulation of T cell mediated cytotoxicity
GO:0001960 negative regulation of cytokine-mediated signaling pathway
GO:0002378 immunoglobulin biosynthetic process
GO:0005001 transmembrane receptor protein tyrosine phosphatase activity
GO:0005887 integral to plasma membrane
GO:0005925 focal adhesion
GO:0006469 negative regulation of protein kinase activity
GO:0006470 protein dephosphorylation
GO:0007411 axon guidance
GO:0019901 protein kinase binding
GO:0030890 positive regulation of B cell proliferation
GO:0033261 regulation of S phase
GO:0042100 B cell proliferation
GO:0045121 membrane raft
GO:0050852 T cell receptor signaling pathway
GO:0050853 B cell receptor signaling pathway
GO:0050857 positive regulation of antigen receptor-mediated signaling pathway
GO:0051209 release of sequestered calcium ion into cytosol
GO:0051607 defense response to virus

MCA87SBY665

100007718

If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.

View more products with CD45 specificity

Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"

View all Anti-Human Products
Please note